DRD1 and drug-induced dyskinesia: We previously demonstrated that systemic coadministration of D1R and D3R agonists results in synergistic increases in both dyskinesia and striatal expression of pERK1/2 [52], supporting previous research demonstrating the site-specific cooperativity of D1R–D3R in downstream signaling [41,77].